Cutaneous IgE‐mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro (Q42278167)
Jump to navigation
Jump to search
scientific article published on May 1, 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cutaneous IgE‐mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro |
scientific article published on May 1, 1993 |
Statements
1 reference
Cutaneous IgE-mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro (English)
1 reference
Cutaneous IgE‐mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro (English)
Lichtenstein LM
1 reference
Kagey-Sobotka A
1 reference
W. A. Massey
E. N. Charlesworth
L. Freidhoff
1 May 1993
1 reference
1 reference
23
1 reference
5
1 reference
399-405
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference